Medicine guide
Penbraya
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed)
- Made by
- Pfizer Europe MA EEIG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Penbraya is indicated for active immunisation of individuals 10 years of age and older to prevent invasive disease caused by Neisseria meningitidis groups A, B, C, W, and Y. The use of this vaccine should be in accordance with official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Pfizer Europe MA EEIG |
|---|---|
| Active substance | Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07AH11 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2024-11-14 |
| Last updated by the regulator | 2025-02-05 |
| EMA product number | EMEA/H/C/006165 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).